ReviewJournal of clinical medicine2025
The Challenges of Postoperative Tissue Flap Vitality Monitoring in Obese Individuals.
Review in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global rise in obesity presents significant challenges for reconstructive surgery. Effective postoperative monitoring of tissue flap vitality is essential for successful outcomes, but obesity introduces complexities that can hinder accurate assessments. This article examines the specific challenges associated with monitoring tissue flap viability in individuals with obesity, focusing on how obesity-related physiological changes affect the effectiveness of various monitoring techniques. We explore alterations in subcutaneous adipose tissue-such as thickness, density, and volume-as well as changes in vessel structure, blood pressure, glucose levels, lactate levels, and tissue perfusion. These factors can impact the accuracy and reliability of monitoring methods. A deep understanding of these challenges is crucial for determining the suitability of different monitoring systems for patients with obesity undergoing flap reconstruction. Based on a review of clinical experience, we assess the usability of widely used monitoring devices, including ultrasound Doppler, near-infrared spectroscopy, and laser Doppler flowmetry, in patients with obesity. Non-conventional techniques such as glucose and lactate measurements, thermography, and fluorescence angiography are also investigated. This article aims to provide a comprehensive overview of the relationship between obesity and tissue flap monitoring, ultimately helping to select the most appropriate and effective methods for this patient population. By considering these factors, surgeons in cooperation with engineers can optimize postoperative care and enhance the likelihood of successful flap reconstruction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.